Radioimmunoguided surgery and colorectal cancer

European Journal of Surgical Oncology

Volumn 22, Issue 4, 1996, Pages 381-388

  Aftab, F ^a   Stoldt, H S ^a   Testori, A ^a   Imperatori, A ^a   Chinol, M ^a   Paganelli, G ^a   Geraghty, J ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Avidin biotin; Monoclonal antibodies; Radioimmunoguided surgery

Indexed keywords

MONOCLONAL ANTIBODY; TRACER;

COLORECTAL CANCER; DIAGNOSTIC IMAGING; HUMAN; ISOTOPE LABELING; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW; SCINTISCANNING;

EID: 0029774367     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)90352-2     Document Type: Article

References (81)

1. Cohen AM, Minsky BD, Schilsky RL. Colon cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology (4 edn). Philadelphia: JP Lippincott, 1993: 929-77.
2. Drebin JA, Neiderhuber JE. Cancer of the lower gastrointestinal tract. In: Neiderhuber JE (ed.) Current Therapy in Oncology. St. Louis: Mosby - Year book, 1992: 426-31.
3. Office of Population Consensuses and Surveys. Mortality Statistics; General Review of the Registrar-General on Death in England and Wales, 1990. Series DHI. No. 24. London: HMSO, 1992: 32.
4. Waagensteen OH, Lewis FJ, Tongen LA. The 'second-look' in cancer surgery. Lancet 1951; 71: 303-7.
5. Waagensteen OH, Lewis FJ, Arhelger SW, et al. An interim report upon the 'second-look' procedure for cancer of the stomach, colon and rectum for 'limited' intraperitoneal carcinosis. Surg Gyne Obst 1954; 99: 257-67.
6. Chu DZJ, Fritsche HA, Lang NP, et al. Resection of recurrent colorectal carcinoma: improved survival with CEA directed second-look laparotomy. J Tumour Mark Oncol 1987; 2: 27-39.
7. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400 patient carcinoembryonic antigen second-look colorectal cancer. Surgery 1985; 55: 1284-90.
8. Martin EW, James KK, Hurtubise PE, et al. The use of CEA as an early indicator of gastrointestinal tumour recurrence and second-look procedures. Cancer 1977; 39: 440-6.
9. Sardi A, Agnone CM, Neiroda CA, et al. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computed tomography and physical examination. South Med J 1989; 82: 1235-44.
10. Sugarbaker PH. Role of CEA in the management of cancer. Adv Immun-cancer Ther 1985; 1: 167-93.
11. Rothenberg DA. Relevant clinical information and tumour markers. Cancer 1993; 71 (Suppl.): 4193-7.
12. Stevenson GW. Radiology and endoscopy in the pretreatment diagnostic management of colorectal cancer. Cancer 1993; 71 (Suppl.): 4198-205.
13. Kelvin FM, Korobkin M, Heaston DK, et al. The pelvis after surgery for colorectal carcinomas: serial CT observations with emphasis on non-neoplastic features. Am J Radiol 1983; 141: 959-64.
14. Hawes RH. New staging techniques: endoscopic ultrasound. Cancer 1993; 71 (Suppl.): 4207-13.
15. Chatal JF. Clinical prospective study with radio-iodinated monoclonal antibodies directed against colorectal cancer. In: Baldwin RW, Byers VS (eds) Monoclonal Antibodies for Cancer Detection and Therapy. Orlando, FL: Academic Press Inc, 1985: 159-80.
16. Back WF, Contrera MA, Grady ED. Factors influencing localisation of antibodies in tumours. Cancer Res 1984; 40: 2965-72.
17. Rollo FD, Patton JA. Imaging techniques for radio-immunodetection of cancer. Cancer Res 1980; 40: 3050-2.
18. Roscoff SD, Goodenough DJ, McIntire KR. Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. Cancer Res 1980; 40: 3054-8.
19. Ehlrich P. The collected papers of Paul Ehlrich. In: Himmelweit F (ed.) Immunology and Cancer Research, Vol. 2. London: Pergamon Press, 1957.
20. Pressman D, Leighley G. The zone of activity of antibodies as determined by the use of radioactive tracers; the zone of nephrotoxic antikidney serum. J Immunol 1948; 59: 141-6.
21. Pressman D, Korngold L. The in vivo localisation of anti-Wagner-osteogenic-sarcoma antibodies. Cancer 1953; 6: 619-23.
22. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122: 467-81.
23. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 1975; 256: 494-7.
24. Mach JP, Carel S, Forni M. Tumour localisation of radiolabeled antibodies against CEA antigen in patients with carcinoma. N Engl J Med 1980; 303: 5-10.
25. Goldenberg DM, Deland F, Kim EE, et al. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980; 40: 2984-92.
26. Begent RH, Stanuras G, Jones BE, et al. Radioimmunodetection of tumours by external scintigraphy after administration of 131 Iodine antibody to human chorionic gonadotrophin: preliminary report. J Roy Soc Med 1980; 73: 629-30.
27. Mach JP, Buchegger F, Forni M, et al. Use of radiolabeled monoclonal anti carcinoembryonic antibodies for the detection of human carcinoma by external photoscanning and tomoscintigraphy. Immunol Today 1981; 2: 239-49.
28. Epenetos AA, Britton KE, Mather S, et al. Targeting of Iodine 123-labeled tumour associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet 1982; II: 999-1004.
29. Delaloye B, Bischof Delaloye A, Buchegger F, et al. Detection of colorectal carcinoma by emission - computerised tomography after injection of 123-Iodine labeled Fab or F(ab')2 fragments from monoclonal anti-CEA antibodies. J Clin Invest 199X; 77: 301-11.
30. Goldenberg DM, Deland FH, Kim EE, et al. Use of radiolabeled antibodies to CEA antigen for the localisation and treatment of diverse cancer by external photoscanning. N Engl J Med 1978; 298: 1384-8.
31. Aitken DR, Hinkle GH, Thurston MO, et al. A gamma detecting probe for radioimmunodetection of CEA producing tumours. Dis Col Rec 1984; 27: 279-82.
32. Martin DT, Aitken D, Thurston M, et al. Successful experimental use of a self contained gamma detecting device. Curr Surg 1984; 41: 193-4.
33. Oredipe OA, Barth RF, Tuttle SE, et al. Limits of sensitivity for the radio-immunodetection of colon cancer by means of a hand-held gamma probe. Nucl Med Biol 1988; 15: 595-603.
34. Larson SM, Brown JP, Wright PW, et al. Imaging of melanoma with 131-iodine-labelled monoclonal antibodies. J Nucl Med 1983; 24: 123-9.
35. Johnson VG, Schlom J, Paterson AJ, et al. Analysis of a human tumour-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46: 850-7.
36. Thor A, Ohuchi N, Szpak CA, et al. The distribution of oncofetal antigen TAG-72 defined by monoclonal antibody B72.3. Cancer Res 1986; 46: 3118-24.
37. Thor A, Viglione MJ, Muraro R, et al. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynae Pathol 1987; 6: 235-47.
38. Wolf BC, D'Emilia JC, Salem RR, et al. Detection of the tumour associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon. J Natl Cancer Inst 1989; 81: 1913.
39. Lottich SC, Szpak CA, Johnston WW, et al. Phenotypic heterogeneity of a tumour associated antigen in adenocarcinoma of colon and their metastasis as demonstrated by monoclonal antibody B72.3. Cancer Invest 1986; 4: 387-955.
40. Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1986; 46: 3225-38.
41. Jain KR, Baxter LT. Mechanisms of heterogenous distribution of monoclonal antibodies and other macromolecules in tumours: significance of elevated interstitial pressure. Cancer Res 1988; 48: 7022-32.
42. Van Osdal W, Fujimoro K, Weinstein JN. An analysis of monoclonal antibody distribution in microscopic tumours: consequences of 'binding site barrier'. Cancer Res 1991; 51: 4776-84.
43. Fujimoro K, Covell DG, Fletcher JE, Weinstein JN. A modeling analysis of monoclonal antibody percolation through tumours: a 'binding site barrier'. J Nucl Med 1990; 31: 1191-8.
44. Juweid M, Sato S, Weinstein JN, Neumann RD. Radiolabelled monoclonal antibody heterogenous distribution caused by a 'binding site barrier': first experimental evidence. J Nucl Med 1992; 33: 893.
45. Lange MK, Martin EW. Monoclonal antibodies in imaging and therapy of colorectal cancer. World J Surg 1991; 15: 617-22.
46. Carrasquillo JA, Krohns KA, Beaumier P. Diagnosis of and therapy for solid tumours with radiolabelled antibodies and immune fragments. Cancer Res Rev 1984; 68: 371.
47. Fujimoro F, Covell DC, Flecher JE, Weinstein JN. Modeling analysis of the global and microscopic distribution of IgG, F(ab′)2, and Fab in tumours. Cancer Res 1989; 49: 5656-63.
48. Goodwin DA, Meares CF, McCall MJ, et al. Pretargeted immunoscintigraphy of murine tumours with indium-111-labelled bifunctional haptens. J Nucl Med 1988; 29: 226-34.
49. Paganelli G, Malcivati M, Fazio F. Monoclonal antibody pretargeting techniques for tumour localisation; the Avidin-Biotin System. Nucl Med Commun 1991; 12: 211-34.
50. LeDoussal JM, Martin M, Gautherot E, Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med 1989; 30: 1358.
51. Schuhmacher J, Klivenyi G, Matys R, et al. Multistep tumour targeting in nude mice using bi-specific antibodies and gallium chelate suitable for immunoscintigraphy with positron emission tomography. Cancer Res 1995; 55: 115-23.
52. Paganelli G, Magnani P, Antonio G, et al. Clinical applications of the avidin-biotin system for tumour targeting. In: Cancer Therapy with Radiolabeled Antibodies. CRC Press, 1995: 239-54.
53. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987; 28: 1294.
54. Sung C, Van Osdol WW. Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding. J Nucl Med 1995; 36: 867-76.
55. Saga T, Weinstein JN, Jeong JM, et al. Two-step targeting of experimental lung metastasis with biotinylated antibody and radiolabeled streptavidin. Cancer Res 1994; 54: 2160-5.
56. Ferrucio F, Paganelli G. Antibody guided scintigraphy: targeting of the 'Magic Bullet'. Eur J Nucl Med 1993; 20: 1138-40.
57. Paganelli G, Magnani P, Zito F, et al. Three step monoclonal antibody tumour targeting in CEA-positive patients. Cancer Res 1991; 51: 5960-6.
58. Modorati G, Brancato R, Paganelli G, et al. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosing of uveal melanoma: preliminary results. Br J Ophthalmol 1994; 78: 19-23.
59. Su-Ming HSU, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Hist Cyt 1981; 29: 577.
60. Goldenberg DM, Kimm EE, Deland PH, et al. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980; 40: 2984-91.
61. Mach JP, Carrel S, Forni M, et al. Tumour localisation of radiolabelled antibodies against CEA in patients with carcinoma: a critical evaluation. N Engl J Med 1980; 303: 5-10.
62. Colcher D, Esteban JM, Carrasquillo JA, et al. Quantitative analysis of selective radio-labelled monoclonal antibody localisation in metastatic lesions of colorectal patients. Cancer Res 1987; 47: 1185-9.
63. O'Dwyer PJ, Mojzisik CA, Hinkle GH, et al. Intra-operative probe directed radio-immunodetection using a monoclonal antibody. Arch Surg 1986; 121: 1391-4.
64. Sickle-Santanello BJ, O'Dwyer PJ, Mojzisik CA, et al. Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumours. Dis Col Rec 1987; 30: 761-4.
65. Martin EW, Mojzisik CA, Hinkle GH, et al. Radioimmunoguided surgery using monoclonal antibody. Am J Surg 1988; 156: 386-92.
66. Sardi A, Workman M, Mojzisik CA, et al. Intra abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS System). Arch Surg 1989; 124: 55-9.
67. Neiroda CA, Mojzisik CA, Sardi A, et al. The impact of radioimmunoguided surgery (RIGS TM) on surgical decision making in colorectal cancer. Dis Col Rec 1989; 32: 927-32.
68. Dawson PM, Blair SD, Begent RHJ, et al. The value of radioimmunoguided surgery in first and second look laparotomy for colorectal cancer. Dis Col Rec 1991; 34: 217-22.
69. Cohen AM, Martin EW Jr, Lavery I, et al. Radioimmunoguided surgery using Iodine 125 B72.3 in patients with colorectal cancer. Arch Surg 1991; 126: 349-52.
70. Di Carlo V, Badellino F, Stella P, et al. Role of B72.3 iodine labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery. Surgery 1994; 115: 190-8.
71. Paganelli G, Stella M, Zito F, et al. Radioimmunoguided surgery using Iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med 1994; 35: 1970-5.
72. Stella M, De Nardi P, Paganelli G, et al. Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Dis Col Rec 1994; 37: 335-43.
73. Arnold MA, Schneebaum S, Berens A, et al. Intra operative detection of colorectal cancer with radioimmunoguided surgery and CC 49, a second generation monoclonal antibody. Ann Surg 1992; 216: 627-32.
74. Arnold MW, Schneebaum S, Berens A, et al. Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 1992; 112: 624-30.
75. Martin EW, Carey LC. Second look surgery for colorectal cancer. Ann Surg 1991; 214: 321-7.
76. Bertsch DJ, Burak WE, Young DC, et al. Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer. Surgery 1995; 118: 634-9.
77. Arnold MW, Young DC, Hitchcock CA, et al. Radioimmunoguided surgery in primary colorectal carcinoma: an intraoperative prognostic tool and adjuvant to traditional staging. Am J Surg 1995; 170: 315-8.
78. Neiroda CA, Mojzisik C, Hinkle G, et al. Radioimmunoguided surgery (RIGS) in recurrent colorectal cancer. Can Del Preven 1991; 15: 225-9.
79. Sardi AA, Siddiqui MA, Rousseau M, et al. Localisation of tumour labeled with antibody 'cocktail' by hand-held gamma probe. J Surg Res 1989; 47: 227-34.
80. Theoni RF. Colorectal cancer: cross sectional imaging for staging of primary tumour and detection of local recurrence. Am J Radiol 1991; 156: 909-16.
81. Epenetos AA, Snook D, Durbin H, et al. Limitations of radiolabeled monoclonal antibodies for localisation of human neoplasm. Cancer Res 1986; 46: 3183-91.